Industry's First Standards of Excellence

Release date: 8/12/2008

Repair Stem Cell Institute Announces Industry's First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics

DALLAS, Aug. 12 /PRNewswire/ -- To protect potential patients from being unwitting victims in the proliferation of less than competent therapeutics, the Repair Stem Cell Institute LLC (RSCI) (http://www.RepairStemCells.org) and its Scientific Advisory Board (SAB) today announced the establishment of the industry's first standards of excellence for Repair Stem Cells(TM) (RSC) treatment centers worldwide who are using RSC, also known as Adult Stem Cells. Among the critical ethical criteria, which are required for facilities to be qualified for the RSCI's list of top treatment centers, are licensing and certification of the treating doctors by their country's medical professional regulatory board.

According to Don Margolis (don@repairstemcells.com; 786-600-1408), founder and chairman of the RSCI, "Regrettably, there is a wave of offshore commercially available less-than-competent stem cell therapeutic practitioners. Their bogus, unwanted extravagant claims, which tout the potential of their stem cell wonder tonics, are hurting the image of the scientifically honest treatment centers that are truly helping people with more than 100 medical conditions.

"It's the responsibility of the RSCI and members of our SAB to establish the industry's first standards of excellence at the highest level for RSC treatment centers worldwide to meet and abide by," Mr. Margolis said. "We must assure people seeking life-changing stem cell therapies that they can expect to receive the best quality therapeutics from the facilities they diligently research."

Along with licensing and certification, the RSCI stipulates stem cell treatment centers must have a successful record of treating patients with RSC for a minimum of six months. The RSC must be either autologous (from the body of the patient) or from umbilical cords. Any other source must be clearly labeled "experimental" until there is a completed successful clinical trial using the experimental source of cells for the disease(s) being treated by the treatment center. Also, the laboratory supplying the stem cells to the treatment center must meet at least minimum recognized current Good Manufacturing Procedure (cGMP) standards. That same laboratory must have over 100 successful RSC human implants to its credit. ("Successful" means having clearly improved the patient's quality of life.)

For a complete listing of RSCI's standards of excellence, click here.

To see RSCI's global listing of stem cell treatment centers and practitioners meeting its standards of excellence, click here. These centers, among them now treating more than 100 different medical conditions, have undeniable records of accomplishments.

About the Repair Stem Cell Institute

The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.